TNF-α production in NKT cell hybridoma is regulated by sphingosine-1-phosphate: Implications for inflammation in atherosclerosis

Coronary Artery Disease

Volumn 25, Issue 4, 2014, Pages 311-320

  Ito, Shiori ^a   Iwaki, Soichiro ^a   Kondo, Rie ^a   Satoh, Masashi ^b   Iwabuchi, Kazuya ^b   Ohkawa, Ryunosuke ^c   Mishima, Yuko ^c   Yatomi, Yutaka ^c   Furumoto, Tomoo ^d   Tsutsui, Hiroyuki ^d   Fujii, Satoshi ^a  

^a NAGOYA CITY UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^d HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

atherosclerosis; flow mediated dilation; FTY720; natural killer T cell; sphingosine 1 phosphate; tumor necrosis factor

Indexed keywords

2 AMINO 2 (3 OCTYLPHENYLCARBAMOYL)ETHYL PHOSPHATE; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; 4 (2,6 DICHLORO 4 PYRIDINYL) 1 (1,3 DIMETHYL 4 ISOPROPYL 1H PYRAZOLO[3,4 B]PYRIDIN 6 YL)SEMICARBAZIDE; ALPHA GALACTOSYLCERAMIDE; CXCL16 CHEMOKINE; FINGOLIMOD; MESSENGER RNA; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; IMMUNOLOGIC FACTOR; LYSOPHOSPHOLIPID; PLASMINOGEN ACTIVATOR INHIBITOR 1; SERPINE1 PROTEIN, HUMAN; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DYSLIPIDEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYBRIDOMA; HYPERTENSION; LYMPHOCYTE MIGRATION; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; C57BL MOUSE; COCULTURE; DRUG EFFECTS; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; LYMPHOCYTE ACTIVATION; METABOLISM; NEUTROPHIL CHEMOTAXIS; RAT; TIME; TUMOR CELL LINE;

ANIMALS; ATHEROSCLEROSIS; CELL LINE, TUMOR; CHEMOTAXIS, LEUKOCYTE; COCULTURE TECHNIQUES; FEMALE; HUMANS; HYBRIDOMAS; IMMUNOLOGIC FACTORS; INFLAMMATION; INFLAMMATION MEDIATORS; LYMPHOCYTE ACTIVATION; LYSOPHOSPHOLIPIDS; MICE, INBRED C57BL; NATURAL KILLER T-CELLS; PLASMINOGEN ACTIVATOR INHIBITOR 1; RATS; RECEPTORS, LYSOSPHINGOLIPID; SIGNAL TRANSDUCTION; SPHINGOSINE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84899949700     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0000000000000082     Document Type: Article

References (32)

1. Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol 2007; 25:297-336
2. Matsuda JL, Mallevaey T, Scott-Browne J, Gapin L. CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system. Curr Opin Immunol 2008; 20:358-368
3. Brennan PJ, Brigl M, Brenner MB. Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions. Nat Rev Immunol 2013; 13:101-117
4. Nakai Y, Iwabuchi K, Fujii S, Ishimori N, Dashtsoodol N, Watano K, et al. Natural killer T cells accelerate atherogenesis in mice. Blood 2004; 104:2051-2059
5. Andoh Y, Fujii S, Iwabuchi K, Yokota T, Inoue N, Nakai Y, et al. Lower prevalence of circulating natural killer T cells in patients with angina: a potential novel marker for coronary artery disease. Coron Artery Dis 2006; 17:523-528
6. Maceyka M, Harikumar KB, Milstien S, Spiegel S. Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol 2012; 22:50-60
7. Ito S, Iwaki S, Koike K, Yuda Y, Nagasaki A, Ohkawa R, et al. Increased plasma sphingosine-1-phosphate in obese individuals and its capacity to increase the expression of plasminogen activator inhibitor-1 in adipocytes. Coron Artery Dis 2013; 24:642-650
8. Sugiura T, Dohi Y, Yamashita S, Ohte N, Ito S, Iwaki S, et al. Analytical evaluation of plasma serotonin and sphingosine 1-phosphate and their clinical assessment in early atherosclerosis. Coron Artery Dis 2012; 23:234-238
9. Sattler KJ, Elbasan S, Keul P, Elter-Schulz M, Bode C, Gräler MH, et al. Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease. Basic Res Cardiol 2010; 105:821-832
10. Samad F, Hester KD, Yang G, Hannun YA, Bielawski J. Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk. Diabetes 2006; 55:2579-2587
11. Lo CG, Xu Y, Proia RL, Cyster JG. Cyclical modulation of sphingosine-1-phosphate receptor 1 surface expression during lymphocyte recirculation and relationship to lymphoid organ transit. J Exp Med 2005; 201:291-301
12. Brinkmann V, Billich A, Baumruker T, Heining P, Schmouder R, Francis G, et al. Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat Rev Drug Discov 2010; 9:883-897
13. Nyambayar D, Iwabuchi K, Hedlund E, Murakawa S, Shirai K, Iwabuchi C, et al. Characterization of NKT-cell hybridomas expressing invariant T-cell antigen receptors. J Clin Exp Hematop 2007; 47:1-8
14. Park SH, Roark JH, Bendelac A. Tissue-specific recognition of mouse CD1 molecules. J Immunol 1998; 160:3128-3134
15. Satoh M, Andoh Y, Clingan CS, Ogura H, Fujii S, Eshima K, et al. Type II NKT cells stimulate diet-induced obesity by mediating adipose tissue inflammation, steatohepatitis and insulin resistance. PLoS One 2012; 7:e30568
16. Diegelmann J, Seiderer J, Niess JH, Haller D, Göke B, Reinecker HC, et al. Expression and regulation of the chemokine CXCL16 in Crohn's disease and models of intestinal inflammation. Inflamm Bowel Dis 2010; 16:1871-1881
17. Rosen H, Stevens RC, Hanson M, Roberts E, Oldstone MB. Sphingosine-1-phosphate and its receptors: structure, signaling, and influence. Annu Rev Biochem 2013; 82:637-662
18. Ohmura K, Ishimori N, Ohmura Y, Tokuhara S, Nozawa A, Horii S, et al. Natural killer T cells are involved in adipose tissues inflammation and glucose intolerance in diet-induced obese mice. Arterioscler Thromb Vasc Biol 2010; 30:193-199
19. Fyrst H, Saba JD. An update on sphingosine-1-phosphate and other sphingolipid mediators. Nat Chem Biol 2010; 6:489-497
20. Allende ML, Zhou D, Kalkofen DN, Benhamed S, Tuymetova G, Borowski C, et al. S1P1 receptor expression regulates emergence of NKT cells in peripheral tissues. FASEB J 2008; 22:307-315
21. Obinata H, Hla T. Sphingosine 1-phosphate in coagulation and inflammation. Semin Immunopathol 2012; 34:73-91
22. Wang F, Okamoto Y, Inoki I, Yoshioka K, Du W, Qi X, et al. Sphingosine-1-phosphate receptor-2 deficiency leads to inhibition of macrophage proinflammatory activities and atherosclerosis in apoE-deficient mice. J Clin Invest 2010; 120:3979-3995
23. Nofer JR, Bot M, Brodde M, Taylor PJ, Salm P, Brinkmann V, et al. FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 2007; 115:501-508
24. Potí F, Gualtieri F, Sacchi S, WeiXen-Plenz G, Varga G, Brodde M, et al. KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/-mice. Arterioscler Thromb Vasc Biol 2013; 33:1505-1512
25. Hwang SJ, Kim JH, Kim HY, Kim S, Chung DH. FTY720, a sphingosine 1-phosphate receptor modulator, inhibits CD1d-restricted NKT cells by suppressing cytokine production but not migration. Lab Invest 2010; 90:9-19
26. Johnston B, Kim CH, Soler D, Emoto M, Butcher EC. Differential chemokine responses and homing patterns of murine TCR ab NKT cell subsets. J Immunol 2003; 171:2960-2969
27. Jiang X, Shimaoka T, Kojo S, Harada M,Watarai H,Wakao H, et al. Cutting edge: critical role of CXCL16/CXCR6 in NKT cell trafficking in allograft tolerance. J Immunol 2005; 175:2051-2055
28. Sugimoto N, Takuwa N, Okamoto H, Sakurada S, Takuwa Y. Inhibitory and stimulatory regulation of Rac and cell motility by the G12/13-Rho and Gi pathways integrated downstream of a single G protein-coupled sphingosine-1-phosphate receptor isoform. Mol Cell Biol 2003; 23:1534-1545
29. Subramanian S, Turner MS, Ding Y, Goodspeed L, Wang S, Buckner JH, et al. Increased levels of invariant natural killer T lymphocytes worsen metabolic abnormalities and atherosclerosis in obese mice. J Lipid Res 2013; 54:2831-2841
30. Iwaki S, Yamamura S, Asai M, Sobel BE, Fujii S. Posttranscriptional regulation of expression of plasminogen activator inhibitor type-1 by sphingosine 1-phosphate in HepG2 liver cells. Biochim Biophys Acta 2012; 1819:1132-1141
31. Deutschman DH, Carstens JS, Klepper RL, Smith WS, Page MT, Young TR, et al. Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate. Am Heart J 2003; 146:62-68
32. Knapp M, Baranowski M, Czarnowski D, Lisowska A, Zabielski P, Gó rski J, et al. Plasma sphingosine-1-phosphate concentration is reduced in patients with myocardial infarction. Med Sci Monit 2009; 15:CR490-CR493